P21WAF1, P27KIP1, TP53 and C-MYC analysis in 204 ovarian carcinomas treated with platinum-based regimens. [electronic resource]
Producer: 20031112Description: 1078-85 p. digitalISSN:- 0923-7534
- Adult
- Aged
- Carcinoma -- drug therapy
- Cell Cycle Proteins -- analysis
- Cyclin-Dependent Kinase Inhibitor p21
- Cyclin-Dependent Kinase Inhibitor p27
- Cyclin-Dependent Kinases -- antagonists & inhibitors
- Cyclins -- analysis
- Enzyme Inhibitors
- Female
- Gene Expression Regulation, Neoplastic
- Genes, Tumor Suppressor
- Humans
- Middle Aged
- Ovarian Neoplasms -- drug therapy
- Prognosis
- Proto-Oncogene Proteins c-myc -- analysis
- Retrospective Studies
- Treatment Outcome
- Tumor Suppressor Protein p53 -- analysis
- Tumor Suppressor Proteins -- analysis
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.